Difference between revisions of "Urothelium"
Jump to navigation
Jump to search
| Line 294: | Line 294: | ||
*T2 - muscularis propria. | *T2 - muscularis propria. | ||
====Subtypes==== | ====Subtypes of urothelial carcinoma==== | ||
There are numerous subtypes:<ref>URL: [http://www.nature.com/modpathol/journal/v22/n2s/full/modpathol200926a.html http://www.nature.com/modpathol/journal/v22/n2s/full/modpathol200926a.html]. Accessed on: 19 August 2011.</ref> | There are numerous subtypes:<ref>URL: [http://www.nature.com/modpathol/journal/v22/n2s/full/modpathol200926a.html http://www.nature.com/modpathol/journal/v22/n2s/full/modpathol200926a.html]. Accessed on: 19 August 2011.</ref> | ||
*Squamous differentiation. | *Squamous differentiation. | ||
Revision as of 17:46, 23 January 2013
The urothelium lines the upper portion of the genitourinary tract, i.e. ureters, urinary bladder), and a bit of the lower part.
Normal histology
- Maturation (cuboidal at base - squamoid at surface).
- Surface cells called 'umbrella cells' (umbrella cells CK20+).
- Urothelium should be 4-5 cell layers thick.
- +/-Prominent nucleoli.
- Should NOT have papillary architecture -- if it does it is likely cancer!
- If it is 'papillary' -- it must have fibrovascular cores.
Extent of urothelium
- Ureters.
- Renal pelvis.
- Urinary bladder.
- Part of the urethra.
Urethra in males
- Pre-prostatic urethra - transitional epithelium.
- Prostatic urethra - transitional epithelium.
- Membranous urethra (from apex of prostate to bulb of penis (bulb of the corpus spongiosusm)) - pseudostratified columnar epithelium.
- Spongy urethra - pseudostratified columnar epithelium (proximal) & stratified squamous (distal).
Approach
Where to start
July 1st PGY-2:
- Urothelial carcinoma - essentially defined by increased nuclear size +/- irreg. nuclear contour.
- Nucleoli are common in urothelium.
- This can be confusing... prostate carcinoma has nucleoli.
- Mitosis - these are key if the nuclear enlargement is not present.[1]
- Cell-depleted urothelium, where the cells have shed-off--but a few remain, should raise suspicions to cancer.
- Thickness of the urothelium, otherwise, isn't very useful for diagnosing cancer.
- Nucleoli are common in urothelium.
- Round structures should make you think of papillae and prompt looking for fibrovascular cores.
- Fibrovascular cores = papillae... may be cancer!
A checklist-like approach
- Papillary structure - with fibrovascular cores?
- Nuclear pleomorphism?
- Yes - high grade (4-5x lymphocyte) --> Dx: high grade papillary urothelial carcinoma
- No - low grade or normal (2-3x lymphocyte) --> DDx: low grade papillary urothelial carcinoma, PUNLMP, papilloma
- Nuclear pleomorphism?
- Flat lesions?
- Nuclear pleomorphism?
- Maturation to surface?
- No --> Dx: sectioning artefact vs. flat UCC.
- Yes --> likely benign.
- Normal thickness?
- Normal is 4-5 cell layers.
- Nests of glandular cells
- Consider cystitis cystica, cystitis glandularis, cystitis cystica et glandularis, Brunn's nest, inverted papilloma.
- Inflammation?
- Michaelis-Gutman bodies?
Pitfalls:
- Urothelial carcinoma of the bladder may be confused with a paraganglioma of the bladder.
- Way to differentiate: paraganglioma = stippled chromatin, UCC = single nucleoli.
Note about terminology
- The bladder is rather unique in that "carcinoma" is a label used for things that are non-invasive.
- It has been suggested that many things that are called papillary urothelial carcinoma, would be better described as papillary intraurothelial neoplasia.[2]
- If the terminology in the urinary bladder were applied to the colon, we'd call all adenomas, i.e. pre-malignant lesions, carcinomas.
Overview in tables
General categorization
Urothelial lesions can broadly be divided into:
- Flat lesions.
- Lack papillae.
- Tend to be more aggressive.
- Papillary lesions.
- Must have true papillae.
- Very common.
- More often benign/indolent.
Flat urothelial lesions
Comparison urothelial changes - flat epithelium - benign/premalignant/cancerous:[3]
| Diagnosis | Nuclear enlargement (X stromal lymphocyte) |
Nucleoli | size var., shape | Polarity | Mitoses | Thickness | Inflammation | Other |
|---|---|---|---|---|---|---|---|---|
| Normal | none (2x) | small | none, round | matures to surface | none/minimal | 4-5 cells | none | - |
| Reactive atypia | moderate, prominent (3x) | prominent | none, round | as normal | some, none atypical | as normal | severe, acute or chronic | - |
| Flat urothelial hyperplasia | none (2x) | small | none, round | as normal | as normal | increased | usu. none | - |
| Urothelial dysplasia | moderate (3x) | small, some multiple | mod. variation, some irregularity | lost | rare, none atypical | as normal | usu. none | - |
| UCC in situ | signif. (4-5x) | +/-large | marked, irregular | lost | common, atypical | thin, thick or norm. | +/- | - |
| Invasive UCC | signif. (4-5X) | +/-large | marked, irregular | lost | common, atypical | thin, thick or norm. | +/- | stromal invasion |
The bold entry is considered the key feature.
Papillary urothelial lesions
Urothelial cells in papillae - benign/premalignant/cancerous:[4][5]
| Diagnosis | Papillae features | Papillae branching | Papillae fusion | Nuclear size | Mitoses | DDx | IHC | Other | Key feature |
|---|---|---|---|---|---|---|---|---|---|
| Papilloma | fat papillae, thick FV core |
rare | none | normal (2x lymphocyte) | very rare basal | PUNLMP, low gr. PUCC | p53-, CK20+ umbrella cells | cytologically normal | normal cells, fat papillae |
| PUNLMP | slender FV core | uncommon | rare | enlarged - uniform | rare basal only | papilloma, low gr. | CK20+ umbrella | low cellular density (@ low power) vs. low gr.[6] | uniformly enlarged cell pop., slender papillae |
| Low grade PUCC | slender FV core, thick epithelium |
frequent | some | enlarged with variation | infreq., usually basal | PUNLMP, high gr. | -/+ p53, CK20+ umbrella | +/- small nucleoli | nuc. pleomorphism, thick epithelium |
| High grade PUCC | mixed population | common | common | 4-5x lymphocyte, marked pleomorphism |
common, everywhere | low gr., invasive UCC | diffuse CK20+, p53+ in 50% | nucleoli prominent | marked nuclear pleomorphism |
Notes:
- FV core = fibrovascular core.
- PUCC = papillary urothelial carcinoma.
Risk factors for urothelial carcinoma
Others:
- Lynch syndrome.
- Should be considered in ureteral cancers.[9]
Flat urothelial lesions
Overview
Several different benign & pre-malignant diagnoses can be made:
- Reactive atypia.
- Flat urothelial hyperplasia.
- Urothelial dysplasia.
- Urothelial carcinoma in situ.
- Invasive urothelial carcinoma.
Urothelial carcinoma in situ
- Abbreviated CIS.
General
- Lack papillae.
Microscopic
Features:
- Nuclear changes key feature.
- Enlargement of nuclei (often 4-5x the size of stromal lymphocytes) -- diagnostic.[10]
- Normal urothelium approx. 2x the size of stromal lymphocytes.
- Nuclear pleomorphism - marked variation in size of nuclei.
- Enlargement of nuclei (often 4-5x the size of stromal lymphocytes) -- diagnostic.[10]
- +/-Disordered arrangement/crowding of cells.
- In normal urothelium the cell line-up on the basement membrane.
- Umbrella cells often absent.
- +/-Mitoses present.
- +/-Enlarged nucleoli.
Note:
- The urothelium may be "depleted", i.e. exist only of rare large cells on the basement membrane.
- This is known as clinging urothelial carcinoma in situ.[11]
Sign out
URINARY BLADDER LESION ("TUMOUR"), TRANSURETHRAL RESECTION URINARY BLADDER TUMOUR (TURBT):
- UROTHELIAL CARCINOMA IN SITU.
- MUSCULARIS PROPRIA PRESENT.
Urothelial cell carcinoma
- See urine cytology for the cytopathology.
- Abbreviated UCC.
- AKA urothelial carcinoma.
General
- These lesions lack papillae and are typical flat.
- Clinically, it may not be possible to differentiate renal pelvis urothelial carcinoma and renal cell carcinoma.
Microscopic
Features:
- Nuclear pleomorphism - key feature.
- Compare nuclei to one another.
- Increased N/C ratio.
- Lack of maturation to surface (important).
- Cells become dyscohesive.
- Mostly useless in my experience.
Invasion vs. in situ: Useful features - present in invasion:[12]
- Thin-walled vessels.
- Stromal reaction (hypercellularity).
- Retraction artefact around the tumour cell nests.
Note:
- The presence/absence of muscle should be commented on in biopsy specimens.
- Adipose tissue may be seen in the lamina propria; tumour adjacent to adipose tissue on a biopsy does not imply invasion deep to the muscularis propria.[13]
Staging
- T1 - lamina propria.
- Several subdivisions of T1 exist:
- T1a - superficial or in muscularis mucosae.
- T1b - beyond muscularis mucosae - into submucosa.
- Several subdivisions of T1 exist:
- T2 - muscularis propria.
Subtypes of urothelial carcinoma
There are numerous subtypes:[14]
- Squamous differentiation.
- Clear cell.
- Plasmacytoid.
- Micropapillary.
- Small nests (< ~10 cells/nest).
- Sarcomatoid.
- Many others...
Benign patterns - mnemonic Much GIN:
- Microcystic.
- Small tubular/glandular.
- Inverted.
- Nested.
Plasmacytoid urothelial cell carcinoma
Features:
- Abundant gray cytoplasm, eccentric nucleus.
Images:
Nested urothelial cell carcinoma
- AKA nested variant urothelial cell carcinoma.
Features:[15]
- High density of well-circumscribed nests.
- Mild-to-moderate nuclear atypia.
- +/-Foci of unequivocal conventional urothelial carcinoma.
- Focally solid or gland fusion.
- Moderate-to-severe nuclear atypia +/- abundant mitoses.
- +/-Extension into the muscularis propria.
DDx:
Images:
- Nested variant of urothelial carcinoma - intermed. mag. (WC).
- Nested variant of urothelial carcinoma - high mag. (WC).
- Nested variant of urothelial carcinoma - very high mag. (WC).
- Several images of NUCC (nih.gov).[16]
IHC
Features:
- CK7 +ve CK20 +ve.
- CK20 may be negative.
UCC vs. Prostate:
- UCC: p63+, PSA-, PSAP-, CK7+, CK20+.
- Prostate: p63-, PSA+, PSAP+, CK7-, CK20-.
UCC vs. RCC:
- UCC: p63+.[17]
Molecular
Not used for diagnosis.
Changes:
- 9p deletion -- site of CDKN2A[18] (AKA p16).
- 17p deletion -- site of PT53 (AKA p53).
Sign out
High grade UCC
URINARY BLADDER LESION ("TUMOUR"), TRANSURETHRAL RESECTION URINARY BLADDER TUMOUR (TURBT):
- INVASIVE HIGH-GRADE PAPILLARY UROTHELIAL CARCINOMA WITH SQUAMOUS DIFFERENTIATION AT LEAST INTO MUSCULARIS PROPRIA.
- LYMPHOVASCULAR INVASION PRESENT.
Papillary urothelial lesions
Papillary urothelial lesions are grouped into one of five categories (listed from good to bad prognosis):[5]
- Urothelial papilloma.
- Inverted papilloma.
- Papillary urothelial neoplasm of low malignant potential (PUNLMP).
- PUNLMP is pronouced "pun-lump".
- Low grade papillary urothelial carcinoma.
- High grade papillary urothelial carcinoma.
Key characteristics:
- Nuclear - size/pleomorphism.
- Papillae branching.
- Papillae fusion.
Urothelial papilloma
General
- Very rare diagnosed.
- If the person has a history of a low grade papillary urothelial carcinoma... it is a low grade papillary urothelial carcinoma.
- These cases are a consensus diagnosis, i.e. you show it to a colleague... if they agree you can call it.
Microscopic
Features:[5]
- Papillary fronds.
- Minimal branching or fusion.
- Cytological features of normal urothelium.
- Normal urothelium approx. 2x the size of stromal lymphocytes.[10]
- No mitoses.
- Thickness < 7 cells.[citation needed]
DDx:
Inverted urothelial papilloma
General
- May be confused with papillary urothelial carcinoma with an inverted growth pattern.
Microscopic
Features:
- Like papillomas... but grow downward.[5]
- According to THvdK,[19] inverted papillomas never have an exophytic component; if an exophytic component is present it is urothelial carcinoma. This is disputed by one paper from Mexico that examines two cases.[20]
- Nests have peripheral palisading of nuclei - important.
DDx:
- Low grade papillary urothelial carcinoma with an inverted growth pattern.
Images:
Papillary urothelial neoplasm of low malignant potential
- Abbreviated PUNLMP.
General
- Uncommon: prevalence ~ 0-3.5%.[21]
- PUNLMP vs. low grade papillary urothelial carcinoma has a poor inter-rater reliability.[22]
Treatment:
- Excision and on-going follow-up - like non-invasive low grade papillary urothelial carcinoma (LGPUC).[23]
Microscopic
Features:[5]
- Rare fused papillae.
- Infrequent mitoses.
- Nuclei larger than papilloma - but monotonous.[25]
DDx:
Images:
Low grade papillary urothelial carcinoma
General
- Very common.
- Very good prognosis - if it is non-invasive.
Microscopic
Features:[5]
- Fused papillae.
- Papillae branch.
- Larger nuclei than PUNLMPs.
- +/-Invasion into the lamina propria.
Note:
- The presence/absence of muscle should be commented on in biopsy specimens.
- Adipose tissue may be seen in the lamina propria; tumour adjacent to adipose tissue on a biopsy does not imply invasion deep to the muscularis propria.[13]
DDx:
Sign out
URINARY BLADDER LESION ("TUMOUR"), TRANSURETHRAL RESECTION OF BLADDER TUMOUR (TURBT):
- LOW-GRADE PAPILLARY UROTHELIAL CARCINOMA.
- NEGATIVE FOR LAMINA PROPRIA INVASION.
- NO MUSCULARIS PROPRIA IDENTIFIED.
URINARY BLADDER LESION ("TUMOUR"), TRANSURETHRAL RESECTION OF BLADDER TUMOUR (TURBT):
- LOW-GRADE PAPILLARY UROTHELIAL CARCINOMA.
- NEGATIVE FOR LAMINA PROPRIA INVASION.
- MUSCULARIS PROPRIA PRESENT.
High grade papillary urothelial carcinoma
- Abbreviated HGPUC.
- AKA high grade urothelial cell carcinoma, abbreviated high grade UCC.
General
- Aggressive.
Microscopic
Features:[5]
- "High grade nuclear features":
- Nuclear pleomorphism - often 4-5x the size of stromal lymphocytes.[10]
- Architectural complexity.
- Fused papillary common.
- Papillae branch.
- Mitoses common.
- +/-Invasion into the lamina propria.
Note:
- The presence/absence of muscle should be commented on in biopsy specimens.
- Adipose tissue may be seen in the lamina propria; tumour adjacent to adipose tissue on a biopsy does not imply invasion deep to the muscularis propria.[13]
DDx:
Sign out
URINARY BLADDER LESION ("TUMOUR"), TRANSURETHRAL RESECTION URINARY BLADDER TUMOUR (TURBT):
- INVASIVE HIGH-GRADE PAPILLARY UROTHELIAL CARCINOMA WITH LAMINA PROPRIA INVASION.
- MUSCULARIS PROPRIA NEGATIVE FOR INVASIVE MALIGNANCY.
- NEGATIVE FOR LYMPHOVASCULAR INVASION.
Invasion into the muscularis propria
URINARY BLADDER LESION ("TUMOUR"), TRANSURETHRAL RESECTION URINARY BLADDER TUMOUR (TURBT):
- INVASIVE HIGH-GRADE PAPILLARY UROTHELIAL CARCINOMA AT LEAST INTO MUSCULARIS PROPRIA.
- LYMPHOVASCULAR INVASION PRESENT.
Low-grade versus high-grade
URINARY BLADDER LESION ("TUMOUR"), TRANSURETHRAL RESECTION URINARY BLADDER TUMOUR (TURBT):
- HIGH-GRADE PAPILLARY UROTHELIAL CARCINOMA, SEE COMMENT.
- NEGATIVE FOR LAMINA PROPRIA INVASION.
- NO MUSCULARIS PROPRIA PRESENT.
COMMENT:
The sections show papillary branching, papillary fusion and scattered large cells (~4-5 a
resting lymphocyte). Atypical for a high-grade lesion is that mitotic activity is scarce
and prominent nucleoli are not present.
Benign urothelial lesions
The big table of cystitis:
| Type | Key feature | DDx | Reference |
|---|---|---|---|
| Florid proliferative cystitis | expanded lamina propria with von Brunn's nests, cystitis cystica et glandularis | von Brunn's nests, cystitis cystica et glandularis, low-grade urothelial carcinoma | [29] |
| Polypoid cystitis | wide base, height > base | papillary cystitis, bullous cystitis | [30] |
| Bullous cystitis | wide base, height < base | papillary cystitis, polypoid cystitis | [30] |
| Papillary cystitis | narrow base, height > base | polypoid cystitis, bullous cystitis | [30] |
| Interstitial cystitis | +/-ulceration (uncommon) - requires clinical correlation | urothelial CIS | [31] |
| Follicular cystitis | lymphoid follicles | non-Hodgkin lymphoma | [32] |
| Infectious cystitis | dependent cause (bacterial, viral, fungal) | [33] | |
| Granulomatous cystitis | granulomas | tuberculosis, schistosomiasis, fungal infection, post-BCG | [33] |
| Radiation cystitis | edema, vascular congestion, +/- erosions -- acute; fibrosis in LP and detrusor -- chronic | [34] |
Interstitial cystitis
General
- Chronic cystitis, culture negative.
- Treatment difficult.[35]
Epidemiology:[36]
- Women > men.
Symptoms:[36]
- Urgency.
- Frequency.
- Pain.
Microscopic
Features:[31]
- +/-Ulceration (uncommon).
Note:
- Diagnosis requires clinical correlation.
DDx:
- Urothelial CIS.
Follicular cystitis
Microscopic
Features:[32]
- Lymphoid follicles in the lamina propria.
DDx:
- Non-Hodgkin lymphoma.
Sign out
URINARY BLADDER, BIOPSY: - UROTHELIAL MUCOSA WITH CHRONIC INFLAMMATION AND BENIGN LYMPHOID NODULES WITH GERMINAL CENTRE FORMATION. - MUSCULARIS PROPRIA PRESENT. - NEGATIVE FOR UROTHELIAL CARCINOMA IN SITU AND NEGATIVE FOR MALIGNANCY.
Polypoid cystitis
General
- Uncommon.
- Wide age range.
- Benign.
Microscopic
Features:[30]
- Polypoid urothelium-covered projections with:
- Broad bases.
- Height > base.
- Extensive edema.
DDx:
- Papillary cystitis - not a broad base.
- Bullous cystitis.
Image:
von Brunn nests
General
- Benign.
Microscopic
Features:[37]
- Nests of (benign) urothelium budding into the lamina propria.
Note:
- Nests should not extend into the muscularis propria.
DDx:
IHC
Features:[38]
- p53 -ve.
- MIB-1 <3%.
Cystitis cystica
General
- Benign.
- Can be thought of as von Brunn nests with cystic change.[39]
- Called ureteritis cystica if it happens in a ureter.
Microscopic
Features:[37]
- Nests of urothelium within the lamina propria with cyst formation, i.e. lumens are present.
Note:
- Nests should not extend into the muscularis propria.
Cystitis glandularis
- Cystitis cystica et glandularis redirects to here.
General
- Benign.
- Can be thought of as cystitis cystica with mucin-secreting cells lining the cystic spaces.[39]
- When seen in conjunction with cystitis cystica it is called cystitis cystica et glandularis.
Note:
Microscopic
Features:[37]
- Nests of urothelium within the lamina propria with cyst formation, i.e. lumens are present.
- Cyst lining cells are cuboidal and/or columnar epithelium.
- Produce mucin.
- +/-Goblet cells, i.e. intestinal metaplasia.[39]
Note:
- Nests should not extend into the muscularis propria.
Sign out
URINARY BLADDER NECK, BIOPSY: - CYSTITIS CYSTICA ET GLANDULARIS. - NEGATIVE FOR MALIGNANCY.
Malakoplakia
Main article: Malakoplakia
Nephrogenic adenoma
General
Features:[43]
- Benign.
- May mimic adenocarcinoma!
- Classic location is the urinary bladder.
- Also reported in ureter and prostatic urethra.
- It is thought to result from displacement of renal tubular cells, as this entity in renal transplant recipients is graft derived.[44]
Microscopic
Features:[43]
- Tubular structures - key feature.
- Hobnailed cells.
- +/-Thick eosinophilic basement membrane.
- Microcystic appearance.
- Usually associated with chronic inflammation.
Notes:
- May mimic vascular/lymphatic channels - can be sorted-out with IHC.
DDx:
- Urothelial carcinoma, microcystic and nested variants.
- Prostatic adenocarcinoma.
- Clear cell adenocarcinoma.
Images:
- www:
- WC:
IHC
Features:[46]
- CK7 +ve.
- PAX2 +ve.
- PAX8 +ve.
- AMACR +ve/-ve.
Others:[43]
- p53 -ve.
- CEA -ve.
- Ki-67 low (<5%).
See also
References
- ↑ JS. 9 June 2010.
- ↑ Van der Kwast, TH.; Zlotta, AR.; Fleshner, N.; Jewett, M.; Lopez-Beltran, A.; Montironi, R. (Dec 2008). "Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminology.". Anal Quant Cytol Histol 30 (6): 309-15. PMID 19160695.
- ↑ Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 155-163. ISBN 978-0443066771.
- ↑ Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 166-175. ISBN 978-0443066771.
- ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 310. ISBN 978-0781765275.
- ↑ GAG. 26 February 2009.
- ↑ Chacko, JA.; Heiner, JG.; Siu, W.; Macy, M.; Terris, MK. (Jan 2006). "Association between marijuana use and transitional cell carcinoma.". Urology 67 (1): 100-4. doi:10.1016/j.urology.2005.07.005. PMID 16413342.
- ↑ URL: http://content.nejm.org/cgi/content/full/343/17/1268. Accessed on: 27 May 2010.
- ↑ Crockett, DG.; Wagner, DG.; Holmäng, S.; Johansson, SL.; Lynch, HT. (May 2011). "Upper urinary tract carcinoma in Lynch syndrome cases.". J Urol 185 (5): 1627-30. doi:10.1016/j.juro.2010.12.102. PMID 21419447.
- ↑ 10.0 10.1 10.2 Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 161. ISBN 978-0443066771.
- ↑ Amin, Mahul B. (2010). Diagnostic Pathology: Genitourinary (1st ed.). Amirsys. pp. 2-55. ISBN 978-1931884280.
- ↑ Sternberg, SE. Histology for Pathologists. P.2047.
- ↑ 13.0 13.1 13.2 Bochner, BH.; Nichols, PW.; Skinner, DG. (Mar 1995). "Overstaging of transitional cell carcinoma: clinical significance of lamina propria fat within the urinary bladder.". Urology 45 (3): 528-31. doi:10.1016/S0090-4295(99)80030-2. PMID 7879346.
- ↑ URL: http://www.nature.com/modpathol/journal/v22/n2s/full/modpathol200926a.html. Accessed on: 19 August 2011.
- ↑ Talbert, ML.; Young, RH. (May 1989). "Carcinomas of the urinary bladder with deceptively benign-appearing foci. A report of three cases.". Am J Surg Pathol 13 (5): 374-81. PMID 2712189.
- ↑ Terada, T. (Oct 2011). "Nested variant of urothelial carcinoma of the urinary bladder.". Rare Tumors 3 (4): e42. doi:10.4081/rt.2011.e42. PMC 3282447. PMID 22355497. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282447/.
- ↑ Langner, C.; Ratschek, M.; Tsybrovskyy, O.; Schips, L.; Zigeuner, R. (Aug 2003). "P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors.". J Histochem Cytochem 51 (8): 1097-9. PMID 12871991.
- ↑ Online 'Mendelian Inheritance in Man' (OMIM) 600160
- ↑ THvdK. 21 June 2010.
- ↑ Albores-Saavedra J, Chable-Montero F, Hernández-Rodríguez OX, Montante-Montes de Oca D, Angeles-Angeles A (June 2009). "Inverted urothelial papilloma of the urinary bladder with focal papillary pattern: a previously undescribed feature". Ann Diagn Pathol 13 (3): 158–61. doi:10.1016/j.anndiagpath.2009.02.009. PMID 19433293.
- ↑ May M, Brookman-Amissah S, Roigas J, et al. (March 2009). "Prognostic Accuracy of Individual Uropathologists in Noninvasive Urinary Bladder Carcinoma: A Multicentre Study Comparing the 1973 and 2004 World Health Organisation Classifications". Eur. Urol. 57 (5): 850. doi:10.1016/j.eururo.2009.03.052. PMID 19346063.
- ↑ MacLennan GT, Kirkali Z, Cheng L (April 2007). "Histologic grading of noninvasive papillary urothelial neoplasms". Eur. Urol. 51 (4): 889–97; discussion 897–8. doi:10.1016/j.eururo.2006.10.037. PMID 17095142.
- ↑ Jones TD, Cheng L (June 2006). "Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts". J. Urol. 175 (6): 1995–2003. doi:10.1016/S0022-5347(06)00267-9. PMID 16697785.
- ↑ Cheng, L.; Maclennan, GT.; Lopez-Beltran, A. (Dec 2012). "Histologic grading of urothelial carcinoma: a reappraisal.". Hum Pathol 43 (12): 2097-108. doi:10.1016/j.humpath.2012.01.008. PMID 22542126.
- ↑ Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 170. ISBN 978-0443066771.
- ↑ Watts, KE.; Montironi, R.; Mazzucchelli, R.; van der Kwast, T.; Osunkoya, AO.; Stephenson, AJ.; Hansel, DE. (Aug 2012). "Clinicopathologic characteristics of 23 cases of invasive low-grade papillary urothelial carcinoma.". Urology 80 (2): 361-6. doi:10.1016/j.urology.2012.04.010. PMID 22857755.
- ↑ Miyamoto, H.; Brimo, F.; Schultz, L.; Ye, H.; Miller, JS.; Fajardo, DA.; Lee, TK.; Epstein, JI. et al. (Aug 2010). "Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.". Arch Pathol Lab Med 134 (8): 1160-3. doi:10.1043/2009-0403-OA.1. PMID 20670136.
- ↑ Isfoss, BL.; Majak, B.; Busch, C.; Braathen, GJ. (Apr 2011). "Simplification of grading papillary urothelial neoplasia using a reduced set of diagnostic features.". Anal Quant Cytol Histol 33 (2): 68-74. PMID 21980608.
- ↑ Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 113. ISBN 978-0443066771.
- ↑ 30.0 30.1 30.2 30.3 Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 120. ISBN 978-0443066771.
- ↑ 31.0 31.1 Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 124. ISBN 978-0443066771.
- ↑ 32.0 32.1 Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 122. ISBN 978-0443066771.
- ↑ 33.0 33.1 Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 127. ISBN 978-0443066771.
- ↑ Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 138. ISBN 978-0443066771.
- ↑ 35.0 35.1 Tanaka, T.; Nitta, Y.; Morimoto, K.; Nishikawa, N.; Nishihara, C.; Tamada, S.; Kawashima, H.; Nakatani, T. (2011). "Hyperbaric oxygen therapy for painful bladder syndrome/interstitial cystitis resistant to conventional treatments: long-term results of a case series in Japan.". BMC Urol 11: 11. doi:10.1186/1471-2490-11-11. PMID 21609485.
- ↑ 36.0 36.1 36.2 French, LM.; Bhambore, N. (May 2011). "Interstitial cystitis/painful bladder syndrome.". Am Fam Physician 83 (10): 1175-81. PMID 21568251.
- ↑ 37.0 37.1 37.2 Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 1028. ISBN 0-7216-0187-1.
- ↑ 38.0 38.1 Volmar, KE.; Chan, TY.; De Marzo, AM.; Epstein, JI. (Sep 2003). "Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma.". Am J Surg Pathol 27 (9): 1243-52. PMID 12960809.
- ↑ 39.0 39.1 39.2 Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 304. ISBN 978-0781765275.
- ↑ Chan, YM.; Ka-Leung Cheng, D.; Nga-Yin Cheung, A.; Yuen-Sheung Ngan, H.; Wong, LC. (Dec 2000). "Female urethral adenocarcinoma arising from urethritis glandularis.". Gynecol Oncol 79 (3): 511-4. doi:10.1006/gyno.2000.5968. PMID 11104631.
- ↑ Yin, G.; Liu, YQ.; Gao, P.; Wang, XH. (Aug 2007). "Male urethritis glandularis: case report.". Chin Med J (Engl) 120 (16): 1460-1. PMID 17825180.
- ↑ Singh, KJ. (Jan 2011). "Mesonephric adenoma in remnant ureteric stump: A rare entity.". Indian J Urol 27 (1): 140-1. doi:10.4103/0970-1591.78414. PMID 21716880.
- ↑ 43.0 43.1 43.2 Gokaslan, ST.; Krueger, JE.; Albores-Saavedra, J. (Jul 2002). "Symptomatic nephrogenic metaplasia of ureter: a morphologic and immunohistochemical study of four cases.". Mod Pathol 15 (7): 765-70. doi:10.1097/01.MP.0000019578.51568.24. PMID 12118115. http://www.nature.com/modpathol/journal/v15/n7/full/3880603a.html. Cite error: Invalid
<ref>tag; name "pmid12118115" defined multiple times with different content - ↑ Mazal, PR.; Schaufler, R.; Altenhuber-Müller, R.; Haitel, A.; Watschinger, B.; Kratzik, C.; Krupitza, G.; Regele, H. et al. (Aug 2002). "Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients.". N Engl J Med 347 (9): 653-9. doi:10.1056/NEJMoa013413. PMID 12200552.
- ↑ Kunju, LP. (Oct 2010). "Nephrogenic adenoma: report of a case and review of morphologic mimics.". Arch Pathol Lab Med 134 (10): 1455-9. doi:10.1043/2010-0226-CR.1. PMID 20923300.
- ↑ Alexiev, BA.; Levea, CM. (Mar 2012). "Nephrogenic Adenoma of the Urinary Tract: A Review.". Int J Surg Pathol. doi:10.1177/1066896912439095. PMID 22415059.